MEDICINAL CHEMISTRY, CHEMICAL SYNTHESIS, AND MASS SPECTROMETRY

药物化学、化学合成和质谱分析

• 批准号: 7954019
• 负责人: Paul R Carlier
• 金额: $ 0.12万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-02-01 至 2010-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7954019
• 关键词: Acetylcholinesterase Inhibitors; Africa South of the Sahara; Alkylation; Alzheimer' s Disease; Anopheles gambiae; Area; Benzodiazepines; Chemistry; Computer Retrieval of Information on Scientific Projects Database; Culicidae; Funding; Grant; Insecticides; Institution; Interest Group; Malaria; Mass Spectrum Analysis; Methods; Multinuclear NMR; NMR Spectroscopy; Organic Synthesis; Pathway interactions; Pharmaceutical Chemistry; Reaction; Reagent; Research; Research Personnel; Resources; Route; SSRI-resistant depression; Source; Structure; United States National Institutes of Health; Work; base; beta secretase; beta-site APP cleaving enzyme 1; biomedical resource; chemical synthesis; inhibitor/antagonist; interest; novel; prevent; reuptake; transmission process

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Medicinal Chemistry. The Carlier group's interests in Medicinal Chemistry encompass three areas. First, they prepare species-selective inhibitors of acetylcholinesterase (AChE) targeting the malaria mosquito (Anopheles gambiae). Such compounds could be deployed on insecticide treated nets to prevent malaria transmission in sub-Saharan Africa. Second, they use click-chemistry based discovery methods to identify BACE1 (beta-secretase) inhibitors; such compounds could be to useful to prevent Alzheimer's disease. Finally, they prepare novel triple reuptake inhibitors to treat SSRI-resistant depression. Enantioselective Synthetic Methods. Organolithium reagents are ubiquitous in organic synthesis. The Carlier group is interested in developing new stereoselective reactions of organolithium compounds and enolates, and in using computation and multinuclear NMR spectroscopy to determine structures and reaction pathways. Recently they developed an enantioselective alkylation route to a new class of (so-called "quaternary") benzodiazepines. A key feature of this work is the intermediacy of transiently non-racemic ("dynamically chiral") intermediates.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此，可以在其他清晰的条目中表示。列出的机构是 对于中心，这不一定是调查员的机构。 药物化学。 Carlier集团对药物化学的兴趣包括三个领域。首先，他们准备靶向疟疾蚊子（Anopheles Gambiae）的乙酰胆碱酯酶（ACHE）的物种选择性抑制剂。这种化合物可以部署在经过杀虫剂处理的网中，以防止撒哈拉以南非洲的疟疾传播。其次，他们使用基于点击化学的发现方法识别BACE1（β-分泌酶）抑制剂；这样的化合物可能有助于预防阿尔茨海默氏病。最后，他们准备了新型的三重再摄取抑制剂，以治疗抗SSRI抑郁症。 对映选择性合成方法。有机矿在有机合成中无处不在。 Carlier组有兴趣开发有机锂化合物和烯醇的新的立体选择反应，以及使用计算和多核NMR光谱来确定结构和反应途径。最近，他们开发了一种对映选择性烷基化途径，向一类新的（所谓的“ Quaternary”）苯二氮卓类药物开发了。这项工作的一个关键特征是瞬时非流行（“动态手性”）中间体的中间体。